Concepedia

Author

Shi-Ken Sha

RELX Group (United States)

Also Known As

Shi-Ken Sha

1

Publications

50

Citations

1

H-Index

0

Concepts

All Affiliations

RELX Group (United States)
SS

About

Shi-Ken Sha is an author at RELX Group (United States).

Shi-Ken Sha

×

1

Publications

50

Citations

1

H-Index

YearCitations

Cell cycle phenotype-based optimization of G2-abrogating peptides yields CBP501 with a unique mechanism of action at the G2 checkpoint

Shi-Ken Sha, Takuji Sato, Hidetaka Kobayashi,

Molecular Cancer Therapeutics

2007

50

Page 1